Organon Co Net Income
| OGN Stock | USD 8.10 0.19 2.29% |
As of the 6th of February, Organon holds the Semi Deviation of 2.26, risk adjusted performance of 0.0845, and Coefficient Of Variation of 978.43. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organon, as well as the relationship between them.
Organon Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.6245 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 777.6 M | 1.3 B | |
| Net Income | 777.6 M | 1.4 B | |
| Net Income From Continuing Ops | 777.6 M | 1.3 B | |
| Net Income Per Share | 3.87 | 7.32 | |
| Net Income Per E B T | 0.96 | 0.73 |
Organon | Net Income | Build AI portfolio with Organon Stock |
Evaluating Organon's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Organon Co's fundamental strength.
Latest Organon's Net Income Growth Pattern
Below is the plot of the Net Income of Organon Co over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Organon financial statement analysis. It represents the amount of money remaining after all of Organon Co operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Organon's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organon's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 864 M | 10 Years Trend |
|
Net Income |
| Timeline |
Organon Net Income Regression Statistics
| Arithmetic Mean | 1,660,017,647 | |
| Geometric Mean | 1,559,189,050 | |
| Coefficient Of Variation | 35.77 | |
| Mean Deviation | 432,800,692 | |
| Median | 1,801,000,000 | |
| Standard Deviation | 593,817,809 | |
| Sample Variance | 352619.6T | |
| Range | 2.4B | |
| R-Value | (0.48) | |
| Mean Square Error | 289349.6T | |
| R-Squared | 0.23 | |
| Significance | 0.05 | |
| Slope | (56,483,333) | |
| Total Sum of Squares | 5641913.4T |
Organon Net Income History
Other Fundumenentals of Organon
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Organon Net Income component correlations
Organon Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Organon is extremely important. It helps to project a fair market value of Organon Stock properly, considering its historical fundamentals such as Net Income. Since Organon's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Organon's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Organon's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Pharmaceuticals sector continue expanding? Could Organon diversify its offerings? Factors like these will boost the valuation of Organon. Anticipated expansion of Organon directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.56) | Dividend Share 0.6 | Earnings Share 1.98 | Revenue Per Share | Quarterly Revenue Growth 0.013 |
Investors evaluate Organon using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organon's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organon's market price to deviate significantly from intrinsic value.
It's important to distinguish between Organon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organon's market price signifies the transaction level at which participants voluntarily complete trades.
Organon 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Organon's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Organon.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Organon on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Organon Co or generate 0.0% return on investment in Organon over 90 days. Organon is related to or competes with Phibro Animal, Aurinia Pharmaceuticals, Nuvation Bio, Avadel Pharmaceuticals, Tilray, Harmony Biosciences, and Mednax. Organon Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies... More
Organon Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Organon's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Organon Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.56 | |||
| Information Ratio | 0.0883 | |||
| Maximum Drawdown | 20.52 | |||
| Value At Risk | (3.98) | |||
| Potential Upside | 6.37 |
Organon Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Organon's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Organon's standard deviation. In reality, there are many statistical measures that can use Organon historical prices to predict the future Organon's volatility.| Risk Adjusted Performance | 0.0845 | |||
| Jensen Alpha | 0.3003 | |||
| Total Risk Alpha | 0.1701 | |||
| Sortino Ratio | 0.1119 | |||
| Treynor Ratio | 0.5337 |
Organon February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0845 | |||
| Market Risk Adjusted Performance | 0.5437 | |||
| Mean Deviation | 2.3 | |||
| Semi Deviation | 2.26 | |||
| Downside Deviation | 2.56 | |||
| Coefficient Of Variation | 978.43 | |||
| Standard Deviation | 3.24 | |||
| Variance | 10.52 | |||
| Information Ratio | 0.0883 | |||
| Jensen Alpha | 0.3003 | |||
| Total Risk Alpha | 0.1701 | |||
| Sortino Ratio | 0.1119 | |||
| Treynor Ratio | 0.5337 | |||
| Maximum Drawdown | 20.52 | |||
| Value At Risk | (3.98) | |||
| Potential Upside | 6.37 | |||
| Downside Variance | 6.55 | |||
| Semi Variance | 5.12 | |||
| Expected Short fall | (2.70) | |||
| Skewness | 1.37 | |||
| Kurtosis | 4.12 |
Organon Backtested Returns
As of now, Organon Stock is somewhat reliable. Organon maintains Sharpe Ratio (i.e., Efficiency) of 0.0446, which implies the firm had a 0.0446 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Organon, which you can use to evaluate the volatility of the company. Please check Organon's Semi Deviation of 2.26, coefficient of variation of 978.43, and Risk Adjusted Performance of 0.0845 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. Organon has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of 0.6, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Organon's returns are expected to increase less than the market. However, during the bear market, the loss of holding Organon is expected to be smaller as well. Organon right now holds a risk of 2.79%. Please check Organon downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Organon will be following its historical price patterns.
Auto-correlation | -0.5 |
Modest reverse predictability
Organon Co has modest reverse predictability. Overlapping area represents the amount of predictability between Organon time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Organon price movement. The serial correlation of -0.5 indicates that about 50.0% of current Organon price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.66 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Organon Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Organon Co reported net income of 864 M. This is 153.16% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 51.32% lower than that of the firm.
Organon Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Organon's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Organon could also be used in its relative valuation, which is a method of valuing Organon by comparing valuation metrics of similar companies.Organon is currently under evaluation in net income category among its peers.
Organon ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Organon's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Organon's managers, analysts, and investors.Environmental | Governance | Social |
Organon Institutional Holders
Institutional Holdings refers to the ownership stake in Organon that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Organon's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Organon's value.| Shares | Geode Capital Management, Llc | 2025-06-30 | 4.4 M | Charles Schwab Investment Management Inc | 2025-06-30 | 3.6 M | Bank Of New York Mellon Corp | 2025-06-30 | 3.6 M | Kahn Brothers & Co Inc /de/ | 2025-06-30 | 3.5 M | Aqr Capital Management Llc | 2025-06-30 | 3.3 M | Private Management Group Inc | 2025-06-30 | 3.1 M | Gotham Asset Management, Llc | 2025-06-30 | 2.7 M | Brandywine Global Investment Mgmt Llc | 2025-06-30 | 2.3 M | Northern Trust Corp | 2025-06-30 | 2.1 M | Vanguard Group Inc | 2025-06-30 | 32.3 M | Blackrock Inc | 2025-06-30 | 31.1 M |
Organon Fundamentals
| Return On Equity | 0.72 | ||||
| Return On Asset | 0.064 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 10.29 B | ||||
| Shares Outstanding | 259.98 M | ||||
| Shares Owned By Insiders | 0.25 % | ||||
| Shares Owned By Institutions | 77.38 % | ||||
| Number Of Shares Shorted | 15.54 M | ||||
| Price To Earning | 4.20 X | ||||
| Price To Book | 2.30 X | ||||
| Price To Sales | 0.34 X | ||||
| Revenue | 6.4 B | ||||
| Gross Profit | 3.51 B | ||||
| EBITDA | 1.6 B | ||||
| Net Income | 864 M | ||||
| Cash And Equivalents | 675 M | ||||
| Cash Per Share | 2.14 X | ||||
| Total Debt | 9.04 B | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 3.48 X | ||||
| Cash Flow From Operations | 939 M | ||||
| Short Ratio | 2.94 X | ||||
| Earnings Per Share | 1.98 X | ||||
| Price To Earnings To Growth | (1.75) X | ||||
| Target Price | 9.36 | ||||
| Number Of Employees | 10 K | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 2.16 B | ||||
| Total Asset | 13.1 B | ||||
| Retained Earnings | 1.01 B | ||||
| Working Capital | 1.63 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 13.1 B | ||||
| Last Dividend Paid | 0.6 |
About Organon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Organon Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organon Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Organon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.Moving together with Organon Stock
Moving against Organon Stock
| 0.82 | HPQ | HP Inc | PairCorr |
| 0.59 | MSFT | Microsoft | PairCorr |
| 0.43 | BRK-A | Berkshire Hathaway | PairCorr |
| 0.32 | IBM | International Business | PairCorr |
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Will Pharmaceuticals sector continue expanding? Could Organon diversify its offerings? Factors like these will boost the valuation of Organon. Anticipated expansion of Organon directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.56) | Dividend Share 0.6 | Earnings Share 1.98 | Revenue Per Share | Quarterly Revenue Growth 0.013 |
Investors evaluate Organon using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organon's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organon's market price to deviate significantly from intrinsic value.
It's important to distinguish between Organon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organon's market price signifies the transaction level at which participants voluntarily complete trades.